Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/09/2012US8283341 Use as medicaments of derivatives of cholest-4-en-3-one, pharmaceutical compositions containing them, novel derivatives and their preparation process
10/09/2012US8283340 Treatment or prophylaxis of proliferative conditions
10/09/2012US8283339 Vinyl phosphonate lysophosphatidic acid receptor antagonists
10/09/2012US8283338 GIP secretion inhibitor
10/09/2012US8283337 Therapeutic or prophylactic agent for vasoconstriction
10/09/2012US8283336 Unit dosage for brain health
10/09/2012US8283335 Lipid composition for improving brain function
10/09/2012US8283334 Inhibitors of TGF-R signaling for treatment of CNS disorders
10/09/2012US8283330 Modulators of pharmacological agents
10/09/2012US8283329 Genetic inhibition of double-stranded RNA
10/09/2012US8283328 nucleotides having modified linkages, used as adjuvants for vaccines useful for treating diseases including cancer, infection, allergies and asthma
10/09/2012US8283327 Palatinose for enhancing dietary supplement and pharmaceutical delivery
10/09/2012US8283326 Crystalline form of 4-(beta-D-glucopyranos-1-yl)-1-methyl-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
10/09/2012US8283316 Methods for treating radiation burns
10/09/2012US8283135 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
10/09/2012US8282958 Coating method
10/09/2012US8282913 Ion binding polymers and uses thereof
10/09/2012US8282912 Compositions for tissue augmentation
10/09/2012US8282909 Pharmaceutical composition for topical application of poorly soluble compounds
10/09/2012US8282607 Sleeve and micro-encapsulated topical analgesic for pain relief
10/09/2012CA2747845C Compositions and methods for dermally treating pain
10/09/2012CA2711685C Modified nodavirus rna for gene delivery
10/09/2012CA2710965C Growing renal tubule cells and ex vivo renal tubule tissue system
10/09/2012CA2682143C Method for extracting secoisolariciresinol and dihydroquercetin from wood
10/09/2012CA2674803C Quinazoline derivatives as angiogenesis inhibitors
10/09/2012CA2674542C Neuroprotection by blood flow stabilization
10/09/2012CA2673435C Succinate salt of 2-((4-(1-methyl-4-(pyridin-4-yl)-1h-pyrazol-3-yl) phenoxy)methyl)quinoline
10/09/2012CA2668997C 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors
10/09/2012CA2660565C Modafinil-based treatment for premature ejaculation
10/09/2012CA2633516C Elongase genes and uses thereof
10/09/2012CA2586239C Methods for regulating weight and size of animals with glycine
10/09/2012CA2575874C Crystalline form of a biphenyl compound
10/09/2012CA2573054C Glycogen or polysaccharide storage disease treatment method
10/09/2012CA2566541C 3-.beta.-d-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof
10/09/2012CA2563237C Appetite-suppressing compositions and methods
10/09/2012CA2556944C Thiazole derivative
10/09/2012CA2551788C Novel carboxamides for use as xa inhibitors
10/09/2012CA2550598C Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method and their use in therapy
10/09/2012CA2546495C Alpha, beta-unsaturated sulfoxides for treating proliferative disorders
10/09/2012CA2544572C Method of coating granules containing mesalazine
10/09/2012CA2544139C Suspension of loteprednol etabonate and tobramycin for topical ophthalmic use
10/09/2012CA2538494C Composition for modulating blood parameters
10/09/2012CA2537355C Condensed ring compound and use thereof
10/09/2012CA2535926C N,n-dihalogenated amino acids and derivatives
10/09/2012CA2533845C Pharmaceutical compositions comprising insulin sensitivity enhancer and another antidiabetic
10/09/2012CA2531097C Process for preparing formulations of lipid-regulating drugs
10/09/2012CA2531011C Thiazolylpiperidine derivatives as mtp inhibitors
10/09/2012CA2526455C 5-membered heterocycle-based p38 kinase inhibitors
10/09/2012CA2520475C Tumor-targeting drug-loaded particles
10/09/2012CA2507835C Sustained improver of muscular fatigue
10/09/2012CA2507100C 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
10/09/2012CA2476594C Mono-and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/09/2012CA2459347C Locked nucleic acid (lna) compositions and uses thereof
10/09/2012CA2459240C Pharmaceutical composition for treating mood disorders
10/09/2012CA2458806C Antisense oligonucleotide against human ache and uses thereof
10/09/2012CA2451047C Use of picropodophyllin derivatives for treatment of igf-1r mediated disorders
10/09/2012CA2451040C Gum resin for topical administration of pharmacologically active agents
10/09/2012CA2448622C Proliposomal drug delivery system
10/09/2012CA2403501C Non-invasive gene targeting to the brain
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/09/2012CA2338712C Use of creatine compounds for treatment of bone or cartilage cells and tissues
10/09/2012CA2243845C Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
10/09/2012CA2229204C Deubiquitinating enzymes that regulate cell growth
10/07/2012CA2738357A1 Methods and compositions to promote ocular health
10/06/2012CA2736441A1 Pyrazolylthiazole compounds as .delta.f508-cystic fibrosis transmembrane conductance regulator correctors
10/04/2012WO2012135868A2 Compositions and methods for the treatment and prevention of cardiac ischemic injury
10/04/2012WO2012135856A2 Very low dose vinorelbine for treatment of cancer
10/04/2012WO2012135817A2 Microrna 130a,b as a tumor suppressor and sensitizing agent for chemotherapy
10/04/2012WO2012135814A2 Microrna29a,b,c as a tumor suppressor and sensitizing agent for chemotherapy
10/04/2012WO2012135808A2 Intraoperative and blood-derived adhesives
10/04/2012WO2012135805A2 Delivery and formulation of engineered nucleic acids
10/04/2012WO2012135801A1 Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
10/04/2012WO2012135799A1 Substituted 3-(1h-benzo{d}imidazol-2-yl)-1h-indazole-analogs as inhibitors of the pdk1 kinase
10/04/2012WO2012135781A1 Combinations of akt inhibitor compounds and chemotherapeutic agents, and methods of use
10/04/2012WO2012135779A1 Combinations of akt and mek inhibitor compounds, and methods of use
10/04/2012WO2012135759A1 Combinations of akt inhibitor compounds and abiraterone, and methods of use
10/04/2012WO2012135757A2 Methods for treating cancer
10/04/2012WO2012135753A1 Combinations of akt inhibitor compounds and erlotinib, and methods of use
10/04/2012WO2012135750A1 Combinations of akt inhibitor compounds and vemurafenib, and methods of use
10/04/2012WO2012135736A2 Modulation of signal transducer and activator of transcription 3 (stat3) expression
10/04/2012WO2012135714A2 Serine biosynthesis pathway inhibition for treatment of cancer
10/04/2012WO2012135697A2 Novel rho kinase inhibitors and methods of use
10/04/2012WO2012135669A1 Nitrogen ring containing compounds for treatment of inflammatory disorders
10/04/2012WO2012135666A1 Inhibitors of metastasis, methods of generating such inhibitors and their therapeutic applications
10/04/2012WO2012135650A1 Derivatives of sulindac, use thereof and preparation thereof
10/04/2012WO2012135641A2 Aurora kinase inhibitors and methods of making and using thereof
10/04/2012WO2012135632A2 Methods of treating a subject having been exposed to a catastrophic event
10/04/2012WO2012135619A2 Intranasal benzodiazepine pharmaceutical compositions
10/04/2012WO2012135617A1 Short -acting dihydropyridines (clevidipine) for use in reducing stroke damage
10/04/2012WO2012135615A2 Enopeptins, uses thereof, and methods of synthesis thereto
10/04/2012WO2012135597A2 Novel, protective, anti-inflammatory receptor and its use in preservation of mitochondrial function, wound healing and repair
10/04/2012WO2012135592A2 Theranostic imaging agents and methods of use
10/04/2012WO2012135588A2 Methods of treating serosal cancer
10/04/2012WO2012135581A1 Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
10/04/2012WO2012135571A1 Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
10/04/2012WO2012135570A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/04/2012WO2012135565A1 Molecular cartesian-coordinate platforms
10/04/2012WO2012135561A1 Formulations comprising 2 -amino- 2- [2- (4 - octylphenyl) ethyl] propane -1, 3 - diol
10/04/2012WO2012135559A1 Menthol liquids composition
10/04/2012WO2012135536A1 Nasal formulations of benzodiazepine
1 ... 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 ... 7860